BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28751163)

  • 21. Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
    Gagini T; de Oliveira Schubach A; de Fatima Madeira M; Maria Valete-Rosalino C; Fernandes Pimentel MI; da Silva Pacheco R
    Parasite; 2017; 24():34. PubMed ID: 28959938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of the Leishmania braziliensis species complex from amplified fragment length polymorphisms, and clinical implications.
    Odiwuor S; Veland N; Maes I; Arévalo J; Dujardin JC; Van der Auwera G
    Infect Genet Evol; 2012 Dec; 12(8):1994-2002. PubMed ID: 22516226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further insight into the geographic distribution of Leishmania species in Peru by cytochrome b and mannose phosphate isomerase gene analyses.
    Kato H; Cáceres AG; Seki C; Silupu García CR; Holguín Mauricci C; Castro Martínez SC; Moreno Paico D; Castro Muniz JL; Troyes Rivera LD; Villegas Briones ZI; Guerrero Quincho S; Sulca Jayo GL; Tineo Villafuerte E; Manrique de Lara Estrada C; Arias FR; Passara FS; Ruelas Llerena N; Kubo M; Tabbabi A; Yamamoto DS; Hashiguchi Y
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007496. PubMed ID: 31220120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Mexican Leishmania species by analysis of PCR amplified DNA.
    Hernandez-Montes O; Monroy-Ostria A; McCann S; Barker DC
    Acta Trop; 1998 Sep; 71(2):139-53. PubMed ID: 9821463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
    Torres DC; Ribeiro-Alves M; Romero GA; Dávila AM; Cupolillo E
    Acta Trop; 2013 May; 126(2):132-41. PubMed ID: 23416123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Bolivian Leishmania braziliensis Cutaneous and Mucosal Leishmaniasis.
    Soto J; Gutiérrez P; Soto P; Paz D; Cayhuara E; Molina C; Sánchez M; Berman J
    Am J Trop Med Hyg; 2022 Jan; 106(4):1182-1190. PubMed ID: 35385826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First Human Cases of Leishmania (Viannia) lainsoni Infection and a Search for the Vector Sand Flies in Ecuador.
    Kato H; Bone AE; Mimori T; Hashiguchi K; Shiguango GF; Gonzales SV; Velez LN; Guevara AG; Gomez EA; Hashiguchi Y
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004728. PubMed ID: 27191391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmania naiffi and lainsoni in French Guiana: Clinical features and phylogenetic variability.
    Ducharme O; Simon S; Ginouves M; Prévot G; Couppie P; Demar M; Blaizot R
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008380. PubMed ID: 32797078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The isolation and molecular characterization of Leishmania spp. from patients with American tegumentary leishmaniasis in northwest Argentina.
    Locatelli FM; Cajal SP; Barroso PA; Lauthier JJ; Mora MC; Juarez M; Kato H; Nasser JR; Hashiguchi Y; Korenaga M; Marco JD
    Acta Trop; 2014 Mar; 131():16-21. PubMed ID: 24291551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility.
    Moreira ES; Anacleto C; Petrillo-Peixoto ML
    Parasitol Res; 1998 Sep; 84(9):720-6. PubMed ID: 9766900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of
    Torrico MC; Fernández-Arévalo A; Ballart C; Solano M; Rojas E; Abras A; Gonzales F; Arnau A; Tebar S; Llovet T; Lozano D; Ariza-Vioque E; Gascón J; Picado A; Torrico F; Muñoz C; Gállego M
    Microbiol Spectr; 2023 Feb; 11(1):e0347722. PubMed ID: 36633426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.
    Adaui V; Lye LF; Akopyants NS; Zimic M; Llanos-Cuentas A; Garcia L; Maes I; De Doncker S; Dobson DE; Arevalo J; Dujardin JC; Beverley SM
    J Infect Dis; 2016 Jan; 213(1):112-21. PubMed ID: 26123565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New World and Old World Leishmania Infections: A Practical Review.
    Kevric I; Cappel MA; Keeling JH
    Dermatol Clin; 2015 Jul; 33(3):579-93. PubMed ID: 26143433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania species identification using FTA card sampling directly from patients' cutaneous lesions in the state of Lara, Venezuela.
    Kato H; Watanabe J; Mendoza Nieto I; Korenaga M; Hashiguchi Y
    Trans R Soc Trop Med Hyg; 2011 Oct; 105(10):561-7. PubMed ID: 21907375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tegumentary leishmaniasis by Leishmania braziliensis complex in Cochabamba, Bolivia including the presence of L. braziliensis outlier: Tegumentary leishmaniasis in Cochabamba, Bolivia: Tegumentary leishmaniasis in Cochabamba, Bolivia.
    Torrico MC; Fernández-Arévalo A; Ballart C; Solano M; Rojas E; Ariza E; Tebar S; Lozano D; Abras A; Gascón J; Picado A; Muñoz C; Torrico F; Gállego M
    Transbound Emerg Dis; 2022 Jul; 69(4):2242-2255. PubMed ID: 34232559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of cutaneous leishmaniasis in the State of Campeche (Yucatan Peninsula), Mexico, over a period of two years.
    Hernández-Rivera MP; Hernández-Montes O; Chiñas-Pérez A; Batiza-Avelar JM; Sánchez-Tejeda G; Wong-Ramírez C; Monroy-Ostria A
    Salud Publica Mex; 2015; 57(1):58-65. PubMed ID: 25629280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A first case of cutaneous leishmaniasis due to Leishmania (Viannia) lainsoni in Bolivia.
    Martinez E; Le Pont F; Mollinedo S; Cupolillo E
    Trans R Soc Trop Med Hyg; 2001; 95(4):375-7. PubMed ID: 11579876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
    Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Miltefosine Combined with Intralesional Pentamidine for
    Soto J; Soto P; Ajata A; Rivero D; Luque C; Tintaya C; Berman J
    Am J Trop Med Hyg; 2018 Nov; 99(5):1153-1155. PubMed ID: 30255833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.